Last ¥614.00 JPY
Change Today +4.00 / 0.66%
Volume 523.0K
As of 2:00 AM 04/18/14 All times are local (Market data is delayed by at least 15 minutes).

kaneka corp (4118) Snapshot

Open
¥615.00
Previous Close
¥610.00
Day High
¥616.00
Day Low
¥609.00
52 Week High
05/22/13 - ¥710.00
52 Week Low
04/19/13 - ¥528.00
Market Cap
214.9B
Average Volume 10 Days
970.6K
EPS TTM
¥44.03
Shares Outstanding
350.0M
EX-Date
03/27/14
P/E TM
13.9x
Dividend
¥16.00
Dividend Yield
2.61%
Current Stock Chart for KANEKA CORP (4118)

Related News

No related news articles were found.

kaneka corp (4118) Related Businessweek News

No Related Businessweek News Found

kaneka corp (4118) Details

Kaneka Corporation manufactures and sells chemicals, functional plastics, expandable plastics and products, foodstuffs products, life science products, electronic products, and synthetic fibers and others in Japan and internationally. The company’s chemical products include polyvinyl chloride (PVC), caustic soda, hydrochloric acid, flexible and rigid PVC compounds, paste PVC, chlorinated PVC, dispersion PVC, and PVC pipes; and functional plastics comprise modifiers, liquid polymers, weather-resistant acrylic films, engineering plastic compounds, processing aid resins, silyl-terminated polyethers, acrylic silicon polymers, modified PET resins, weather-resistant acrylic films, and PVC/acrylic solution-type resins. Its expandable plastics and products consist of extruded polystyrene foam boards, polyolefin foam, and expandable polystyrene; and foodstuffs products include margarine and shortenings, confectionery fats, cacao butter substitute, bakery yeast, creams, and spices. The company’s life science products include Kaneka Coenzyme Q10, a functional foodstuff for use in various food materials, including supplements; Kaneka QH, which helps to maintain the health of middle-aged and older people whose regenerative abilities have declined; Kaneka Glavonoid, a food product ingredient to maintain health among middle-aged and older people; AMMPA Kaneka, an intermediate for anti-hypertensive captopril; Kaneka Glutathione for hepatic medicine; catheters for the treatment of inside blood vessels; intermediates for antibiotics; membrane-type plasmaseparators; LDL-cholesterol adsorption systems; and adsorption columns for SLE and dialysis-related amyloidosis. Its electronic products comprise polyimide and transparent films, bonded magnets, solar modules, optical materials, thermal-conductive graphite sheets, and wooden house construction systems; and synthetic fibers consist of modacrylic fibers. The company is headquartered in Osaka, Japan.

8,600 Employees
Last Reported Date: 06/27/13

kaneka corp (4118) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

kaneka corp (4118) Key Developments

Kaneka Corporation Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2013; Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2014; Provides Dividend Guidance for the Year Ending March 31, 2014

Kaneka Corporation reported consolidated earnings results for the nine months ended December 31, 2013. For the period, the company reported net sales of JPY 391,036 million compared to JPY 353,262 million a year ago. Operating income was JPY 18,572 million compared to 11,757 million a year ago. Ordinary income was JPY 19,924 million compared to JPY 12,049 million a year ago. Net income was JPY 12,134 million or JPY 35.98 per fully diluted share compared to JPY 6,622 million or JPY 19.64 per fully diluted share a year ago. Net cash provided by operating activities was JPY 26,537 million compared to JPY 19,832 million a year ago. Purchase of property, plant and equipment was JPY 26,407 million compared to JPY 24,903 million a year ago. Purchase of intangible assets was JPY 1,931 million compared to JPY 1,504 million a year ago. Income before income taxes and minority interests was JPY 18,448 million as compared to JPY 10,931 million a year ago. The company expects to pay a final dividend of JPY 8.00 per share for the year ending March 31, 2014. The company provided consolidated earnings guidance for the full year ending March 31, 2014. For the period, the company expects net sales of JPY 530,000 million, operating income of JPY 30,000 million, ordinary income of JPY 28,000 million and net income of JPY 15,000 million or JPY 44.52 per share.

Kaneka Announces Earnings Results for the Nine Months Ended December 2013

Kaneka announced earnings results for the nine months ended December 2013. For the period, the company announced 83% increase in net profit to JPY 12.1 billion ($118 million) from the same time a year earlier because sales increased in all its segments. Operating profit for April-December 2013 rose by 58% year on year to JPY 18.6 billion, with net sales up by 11% to JPY 391.0 billion.

Kaneka Corporation to Report Q3, 2014 Results on Feb 10, 2014

Kaneka Corporation announced that they will report Q3, 2014 results on Feb 10, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4118:JP ¥614.00 JPY +4.00

4118 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
GrafTech International Ltd $11.24 USD +0.13
Metabolix Inc $0.94 USD -0.0098
Mitsui Chemicals Inc ¥247.00 JPY -1.00
Toyota Tsusho Corp ¥2,635 JPY -24.00
View Industry Companies
 

Industry Analysis

4118

Industry Average

Valuation 4118 Industry Range
Price/Earnings 14.4x
Price/Sales 0.4x
Price/Book 0.8x
Price/Cash Flow 11.6x
TEV/Sales 0.2x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KANEKA CORP, please visit www.kaneka.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.